Advantage Investment Management’s GSK GSK Stock Holding History

Advantage Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$70K	Hold	1,320	–	–	0.05%	285
2019 Q2	$66K	Hold	1,320	–	–	0.05%	289
2019 Q1	$69K	Hold	1,320	–	–	0.05%	283
2018 Q4	$63K	Hold	1,320	–	–	0.05%	303
2018 Q3	$66K	Hold	1,320	–	–	0.04%	342
2018 Q2	$67K	Hold	1,320	–	–	0.05%	321
2018 Q1	$64K	Hold	1,320	–	–	0.02%	341
2017 Q4	$59K	Buy	1,320 +82	+7%	+$3.79K	0.02%	372
2017 Q3	$63K	Buy	1,238 +158	+15%	+$8.02K	0.02%	350
2017 Q2	$58K	Buy	1,080 +80	+8%	+$4.26K	0.02%	335
2017 Q1	$53K	Hold	1,000	–	–	0.02%	329
2016 Q4	$48K	Sell	1,000 -80	-7%	-$3.95K	0.02%	335
2016 Q3	$58K	Hold	1,080	–	–	0.02%	297
2016 Q2	$59K	Sell	1,080 -160	-13%	-$8.43K	0.03%	316
2016 Q1	$63K	Sell	1,240 -160	-11%	-$7.97K	0.03%	291
2015 Q4	$71K	Hold	1,400	–	–	0.04%	282
2015 Q3	$67K	Hold	1,400	–	–	0.04%	278
2015 Q2	$73K	Hold	1,400	–	–	0.04%	285
2015 Q1	$81K	Buy	1,400 +920	+192%	+$52.7K	0.05%	272
2014 Q4	$26K	Buy	+480	New	+$26.9K	0.02%	388

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Advantage Investment Management's GSK Position: Q3 2019 in Review

Advantage Investment Management held its GSK (GSK) position steady in Q3 2019 at 1,320 shares worth $70K. The position accounts for 0.05% of the portfolio, ranked #285.

Advantage Investment Management first reported a position in GSK in Q4 2014 and has held it in 20 quarters since. The position peaked at $81K in Q1 2015. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

Advantage Investment Management held 1,320 shares of GSK worth $70K as of Q3 2019.
Advantage Investment Management left its GSK share count unchanged in Q3 2019.
GSK made up 0.05% of Advantage Investment Management's portfolio in Q3 2019, its #285 holding.
Advantage Investment Management first reported a position in GSK in Q4 2014 and has held it in 20 quarters since.
Advantage Investment Management's GSK position peaked at $81K in Q1 2015.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.